COULTER® LH 750 HEMATOLOGY ANALYZER
Report
- Report Number
- 1061932-2013-00609
- Event Type
- Malfunction
- Date Received
- April 10, 2013
- Date of Event
- March 12, 2013
- Report Date
- March 12, 2013
- Manufacturer
- BECKMAN COULTER
- Product Code
- GKZ
- PMA / PMN Number
- K011342
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MI, US
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
RESULTS: GHT SCATTER PREAMPLIFIER. (B)(4).
THE CUSTOMER REPORTED GENERATING NON-NUMERIC, INSTRUMENT-GENERATED, INCOMPLETE RESULT FLAGS (RETIC DOTS) FOR RETIC PARAMETERS INVOLVING THE COULTER LH 750 HEMATOLOGY ANALYZER. NO DATA IS AVAILABLE FOR THIS EVENT AS THERE WAS NO IMPACT TO PATIENT RESULTS. THERE WAS NO CHANGE OR AFFECT TO PATIENT TREATMENT IN CONNECTION WITH THIS EVENT. A BECKMAN COULTER FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED AND DISCOVERED THAT THE RINSE LINE FOR THE RETIC CHAMBER HAD A SMALL CUT. THE FSE STATED THAT THE INSTRUMENT DID NOT LEAK FLUID THROUGH THE CUT TUBING. THE FSE REPLACED THE TUBING BUT THE INSTRUMENT STILL GENERATED RETIC DOTS. THE FSE REPLACED THE LIGHT SCATTER PREAMPLIFIER AND THE INSTRUMENT GAVE PROPER RETIC VALUES. LASER AND RETIC MOTOR ASSEMBLY WAS ALSO REPLACED AS A PREVENTIVE MEASURE. UPON FURTHER INSPECTION, THE FSE DISCOVERED THAT PINCH VALVE VL45 WAS BROKEN. THE BROKEN PINCH VALVE DID NOT CAUSE ANY LEAKS AND THE FSE PROCEEDED TO REPLACE THE PINCH VALVE. REPAIRS WERE VERIFIED PER ESTABLISHED PROCEDURES AND RESULTS MET PUBLISHED SPECIFICATIONS. THE CAUSE OF THE RETIC DOTS CAN BE ATTRIBUTED TO THE LIGHT SCATTER PREAMPLIFIER. THE FSE STATED THAT NO RAW DATA IS AVAILABLE FOR THIS EVENT. PINCH VALVE VL45 CONTROLS THE DELIVERY OF STABILYSE TO THE DIFF MIXING CHAMBER AND MAY AFFECT RESULTS FOR DIFF PARAMETERS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 153447 | COULTER® LH 750 HEMATOLOGY ANALYZER | COUNTER, DIFFERENTIAL CELL | GKZ | BECKMAN COULTER | NA | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |